公司资料
PainReform 股价、新闻与催化剂
- 股票代码:
- PRFX
- 交易所:
- NASDAQ
- 行业:
- Biopharma
- 所在地:
- Israel and listed in the U
股票表现
0.95 USD (0.00%)
收盘价
最后更新: 2026年10月1日
1.75M USD
市值
股价为何变动
截至 2026年10月1日，PRFX 股价变化不大，收于 $0.9503。当前新闻监测窗口内未发现新的同公司新闻。
公司概览
业务概览
PainReform is a specialty pharmaceutical company focused on pain management and formulation technology. Its story is built around improving local analgesia through delivery science rather than broad drug discovery.
所在地与行业分类
PainReform is headquartered in Israel and listed in the U.S. market. It sits in specialty pharma and pain management.
商业模式特征
The company depends on clinical progress, formulation validation, and commercialization strategy. Investors typically watch data, market access, and capital runway.
生物医药行业定位
PainReform occupies a niche pain-formulation position within healthcare. The stock is driven by whether its delivery platform can matter in a crowded pain market.
未来催化剂
- PainReform’s catalysts are regional-anesthesia products and any update that shows the platform can still gain commercial traction. The company still needs stronger adoption.
近期新闻
新闻标题由机器翻译，详情为英文原文。
相似股票
商业成熟度、治疗领域或催化剂模式相近的同行公司。